baber/WOPTO huggingface dataset:
Patent NZ-540600-A (NZ)
Title: Nonwoven layer for a filter and filter medium
Inventor: SAUER RALF
IPC: B01D39/18
Filed: 2003-12-08
Abstract: The invention is directed to a nonwoven layer for a filter, in particular, for a vacuum cleaner bag, wherein at least one region of the nonwoven layer, the region having a predetermined thickness and a predetermined area, has an average pore size smaller than 50 mu m and comprises fibres being bonded together such that a movement of the fibres relative to each other in a direction parallel to the surface of the layer is inhibited. The invention is further directed to a filter medium, in particular, for a vacuum cleaner bag, comprising a filter structure wherein a surface or an interface of the filter structure is provided with a filter paper layer having a smaller surface area than the filter structure.
Patent NZ-542372-A (NZ)
Title: Intraparietal aortic valve reinforcement device and a reinforced aortic valve
Inventor: ANDRIEU RAYMOND
IPC: A61F2/24
Filed: 2004-03-08
Abstract: An intraparietal reinforcement device (1) for use in a biological prosthesis (10), as well as a biological prosthesis provided with a device of this type. The device is particularly suitable for use within the organic tissue of the biological prosthesis, and for reinforcing the structure of the prosthesis so that it retains its shape once implanted.
Patent NZ-542599-A (NZ)
Title: Pneumatic animal concussion stunner
Inventor: JONES ARTHUR
IPC: A22B3/02
Filed: 2003-09-30
Abstract: A pneumatically operated animal stunner achieves a high stunning energy to produce concussion and stun an animal without penetration by accelerating a lightweight stunning rod to high speed. To minimize weight, the stunning rod is preferably hollow and made of a lightweight material. A piston sliding within a cylinder with an anti-friction coating drives the stunning rod. The cylinder is pressurized before operation and a catch restrains the piston until it is triggered. To increase stunning rod speed, air is vented ahead of the stunning rod to prevent a build-up of pressurized air that may slow the rod. One end of the stunning rod is provided with a large diameter impact head of a material that resists deformation. The opposite end is made of a wear resistant material and is engaged by the catch. The extension distance of the impact head beyond the front end of the tool is limited and can preferably be adjusted. A specially shaped air-cooled internal bumper is provided to absorb the very high stunning energy of the stunning rod without damage.
Patent NZ-546893-A (NZ)
Title: A safety locking device for a quick hitch/coupler of an earth working machine
Inventor: CALVERT MATTHEW JAMES
Filed: 2006-05-02
Abstract: A safety locking device 18 for a quick hitch/coupler 10 of an earth working machine includes a locking element 21 which is biased into a locking position to automatically lock a front pin of an implement when it is engaged in a hook 14 of the coupler 10. The safety locking device 18 has a hydraulic mechanism to move the locking element 21 to an unlocking position. The hydraulic supply to the safety locking device 18 is independent of a hydraulic supply to a locking mechanism of the coupler 10.
Patent NZ-547570-A (NZ)
Title: Stable liquid pesticide compositions
Inventor: PALLAS NORMAN R
Filed: 2002-05-21
Abstract: Disclosed is a liquid herbicidal concentrate emulsion composition having a continuous aqueous phase and a discontinuous oil phase, the composition comprising: a herbicidal component consisting of a water soluble herbicidal component comprising glyphosate predominantly in the form of the potassium, monoammonium, diammonium, sodium, monoethanolamine, n-propylamine, ethylamine, ethylenediamine, hexamethylenediamine or trimethylsulfonium salt thereof, in solution in said aqueous phase in a concentration that is biologically effective when the composition is diluted in a suitable volume of water to form an enhanced application mixture and applied to foliage of a susceptible plant; an oil phase comprising a substantially water-immiscible organic solvent; and a surfactant component in solution or stable suspension, emulsion, or dispersion in said aqueous phase, the surfactant component comprising one or more surfactants and a stabilizer, the surfactant component being present in a concentration sufficient to provide acceptable temperature stability of the emulsion such that the emulsion has a cloud point of at least 50 deg C and a crystallization point not greater than -10 deg C. Also disclosed is a liquid herbicidal concentrate emulsion composition having a continuous aqueous phase and a discontinuous oil phase, the composition comprising: a herbicidal component consisting of a water soluble herbicidal component comprising a water-soluble herbicide dissolved in said aqueous phase, the water soluble herbicide being present in a concentration that is biologically effective when the composition is diluted in a suitable volume of water and applied to the foliage of a susceptible plant; an oil phase comprising a substantially water-immiscible organic solvent; and a surfactant component in solution or stable suspension, emulsion, or dispersion in said aqueous phase, the surfactant component comprising at least one cationic surfactant and a stabilizer, the surfactant component being present in a concentration sufficient to provide acceptable temperature stability of the emulsion such that the emulsion has a cloud point of at least 50 deg C and a crystallization point not greater than 0 deg C.
Patent NZ-548190-A (NZ)
Title: Method and device for creating micro-arrays
Inventor: LEIGHTON STEPHEN B
Filed: 2000-10-10
Abstract: A method and device are provided for simultaneously creating a plurality of identical micro-arrays of biological samples. The device comprises a substrate having a top side, a bottom side, and a pattern of through-holes. Each through-hole has a wider upper cross-section and a narrower lower cross-section. A surface of at least one through-hole is provided with a deposit of an immobilised analyte-specific reagent. A step or plateau may be formed in at least one of the through-holes. When the substrates are stacked, through-holes are in registry and form tunnels extending through the stack of substrates. Reagents of interest are caused to flow through the tunnels and deposit on the step or plateau area. A barrier layer may be provided to prevent leak-through between neighbouring holes. After the desired reagents have been deposited, the substrates are separated. In this manner a series of micro-arrays, each capable of containing hundreds or thousands of biological samples such as cDNA fragments, is formed simultaneously.
Patent NZ-552872-A (NZ)
Title: RNAI probes targeting cancer-related proteins
Inventor: JANSEN BURKHARD
IPC: A61K31/712
Filed: 2003-08-21
Abstract: Disclosed is an RNAi molecule having a length of less than 49 bases and having a sequence effective to mediate degradation or block translation of mRNA that is the transcriptional product of a first target gene encoding IGFBP-2 and a second target gene encoding IGFBP-5. Also disclosed is the use of the RNA molecule to treat cancer.
Patent NZ-566577-A (NZ)
Title: Methods for producing betamimetics
Inventor: KRUEGER THOMAS
IPC: C07C205/45
Filed: 2006-08-10
Abstract: Disclosed is a process for preparing a 6-hydroxy-8-[(1R)-1-hydroxy-2-[[2-aryl-1,1-dimethyl-ethyl]-amino]ethyl]-2H-1,4-benzoxazin-3(4H)-one of formula 1 wherein n denotes 1 or 2; R1 denotes hydrogen, halogen, alkyl or O-alkyl; R2 denotes hydrogen, halogen, alkyl or O-alkyl; R3 denotes hydrogen, alkyl, OH, halogen, O-alkyl, O--alkylene-COOH, O-alkylene-COO-alkyl; in which a 8-(haloacetyl)-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one of formula 2a, wherein PG represents a protective group and R4 denotes halogen, is reacted with DIP chloride (diisopinocampheylchloroborane) in a suitable solvent to obtain a 8-(2R)oxiranyl-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one of formula 1a, wherein PG has the meaning given above, which is reacted with a compound of formula 1b, wherein R1, R2, R3 and n have the meaning given above, in an organic solvent to obtain a 8-[(1R)-1-hydroxy-2[[2-(4-aryl-1, 1-dimethyl-ethyl]-amino]ethyl]-2H-1,4-benzoxazin- 3(4H)-one of formula 1c, wherein R1, R2, R3, n and PG have the meanings given above, and the compound of formula 1 is obtained there from by cleaving the protective group PG.
Patent NZ-566737-A (NZ)
Title: 7-[2-[4-(6-Fluoro-3-methyl-1,2-benzisoxazol-5-YL)-1-piperazinyl]ethyl]-2(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5 amine
Inventor: BOYLE CRAIG D
IPC: A61P25/16
Filed: 2006-09-21
Abstract: Disclosed is 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e ]-[1 ,2,4]-triazolo[1,5-c]pyrimidin-5-amine having the structural formula (I) or a pharmaceutically acceptable salt thereof for treating Parkinson's Disease, Extra-Pyramidal Syndrome, restless legs syndromeHuntington's Disease, attention deficit hyperactivity disorder, cognitive impairment, negative symptoms of schizophrenia, depression, stroke or psychoses or attention deficit hyperactivity disorder.
Patent NZ-575624-A (NZ)
Title: Biaryl ether urea compounds
Inventor: FAY LORRAINE KATHLEEN
IPC: A61P29/02
Filed: 2007-10-05
Abstract: Disclosed herein are biaryl ether urea compounds of formula (I), particularly compounds of formula III and IV, wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compound and uses thereof. Said compounds are useful inhibitors of fatty acid amide hydrolase (FAAH) and therefore such compounds, in particular N-pyridazin-3-yl-4-(3-{ [5-(trifluoromethyl)pyridine-2-yl]oxy} benzylidene)piperidine-1-carboxamide, are useful in the treatment of pain, urinary incontinence, overactive bladder, emesis, cognitive disorders, anxiety, depression, sleeping disorders, eating disorders, movement disorders, glaucoma, psoriasis, multiple sclerosis, cerebrovascular disorders, brain injury, gastrointestinal disorders, hypertension, rheumatoid arthritis, osteoarthritis or cardiovascular disease.
Patent NZ-578816-A (NZ)
Title: Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation
Inventor: CHEDOTAL ALAIN
IPC: A61K35/12
Filed: 2008-02-04
Abstract: Provided is an in vitro method for promoting proliferation, differentiation, or survival of oligodendrocytes, comprising contacting said oligodendrocytes with an effective amount of a composition comprising an isolated semaphorin 6A ("Sema6A") polypeptide. The compound is useful for treating diseases involving demyelination of damaged nerves.
Patent NZ-578846-A (NZ)
Title: Gnaq mutations in melanoma
Inventor: BASTIAN BORIS C
IPC: A61K39/395
Filed: 2008-02-08
Abstract: Provided is a method of detecting a melanocytic neoplasm cell in a biological sample from a patient, the method comprising: detecting the presence or absence of an activating mutation in a Gnaq gene in the biological sample, wherein the presence of the mutation is indicative of the presence of the melanocytic neoplasm cells in the biological sample. Such diagnosed patients can be treated with various Gnaq antagonists.
Patent NZ-584122-A (NZ)
Title: Lightweight robust thin flexible knitted polymer coated glove
Inventor: THOMPSON ERIC
IPC: A41D19/00
Filed: 2009-09-04
Abstract: A glove with finger 101 to 104, thumb 106 and palm 107 components has a liner knitted from a yarn of denier 221 or less that is coated with a polymeric latex coating adhered to the liner. Reinforcement sections 111 to 118 are knitted into the liner at the base of the fingers, thumb and in the palm component.
Patent NZ-584787-A (NZ)
Title: Inhibition of angiogenesis with a Bv8 antagonist
Inventor: FERRARA NAPOLEON
IPC: A61P35/00
Filed: 2008-09-19
Abstract: Disclosed is the use of an anti-Bv8 antagonist antibody or functional fragment thereof in the manufacture of a medicament for treating an anti-VEGF resistant tumour. Further disclosed is a method for identifying an anti-VEGF resistant tumour-bearing human subject for treatment with an anti-Bv8 antagonist antibody or functional fragment thereof, comprising determining in a sample obtained from the subject, that the subject is refractory to treatment with a VEGF antagonist.
Patent NZ-589368-A (NZ)
Title: A syringe cartridge applicator with a syringe cap removal mechanism that operates on advance of a syringe
Inventor: HOLMES ROBERT WILLIAM LACHLAN
IPC: A61M5/28
Filed: 2009-03-11
Abstract: A syringe cartridge holding assembly is disclosed. The assembly is used as a component in a syringe cartridge applicator (300). The assembly has a pair of opposing side walls having a cap removing means (302) thereon which is adapted to remove a protective cap from a syringe cartridge by contacting one or more protruding shoulders of the protective cap as the syringe cartridge is moved by the applicator into a dispensing position.
Patent NZ-590744-A (NZ)
Title: Method and apparatuses for maintaining service continuity to a centralization and continuity application server
Inventor: LINDHOLM FREDRIK
IPC: H04L69/40
Filed: 2008-08-28
Abstract: 590744 Disclosed is a method of maintaining service continuity for User Equipment accessing an IP Multimedia Subsystem communication network. The method includes establishing a routing identifier that identifies a Service Centralisation and Continuity Application Server allocated to the User Equipment. The method also includes sending the routing identifier to the User Equipment and in the event of disruption to the service between the User Equipment and the Service Centralisation and Continuity Application Server, sending a handover message from the User Equipment via a Circuit Switched access network. The handover message includes the routing identifier. The method further includes forwarding the handover message to the identified Service Centralisation and Continuity Application Server.
Patent NZ-597748-A (NZ)
Title: A wireless power supply
Inventor: STONER JR WILLIAM T
IPC: H02J5/00
Filed: 2010-07-23
Abstract: A multi-input wireless power supply comprises an AC/DC rectifier circuit capable of accepting a first input voltage or a second input voltage and the AC/DC rectifier produces a rectified output, a sensor for detecting which of the first input voltage and the second input voltage is connected to the multi-input wireless power supply; a plurality of switching circuits each coupled to the rectified output; a first tank circuit coupled to one of the plurality of switching circuits and the characteristics of the first tank circuit are selected for transferring power to a remote device as a function of the first input voltage; a second tank circuit coupled to a different of the plurality of switching circuits, and the characteristics of the second tank circuit are selected for transferring power to the remote device as a function of the second input voltage with the characteristics of the second tank circuit are different from the characteristics of the first tank circuit; a low power DC/DC converter coupled to the AC/DC rectifier for converting the rectified output; a microcontroller coupled to the low power DC/DC converter. The microcontroller is programmed to control the plurality of switching circuits based on output from the sensor. Also disclosed is a multi-input wireless power supply comprising a rectifier circuit capable of accepting a first input voltage or a second input voltage and the rectifier circuit produces a rectified output; a plurality of switching circuits each coupled to the rectified output; a first tank circuit coupled to one of the plurality of switching circuits and the characteristics of the first tank circuit are selected for transferring power to a remote device as a function of the first input voltage without being converted by a DC/DC converter; a second tank circuit coupled to a different of the plurality of switching circuit and the characteristics of the second tank circuit are selected for transferring power to the remote device as a function of the second input voltage without being converted by a DC/DC converter with the characteristics of the second tank circuit are different from the characteristics of the first tank circuit; and a microcontroller programmed to control the plurality of switching circuits.
Patent NZ-598515-A (NZ)
Title: Pharmaceutical preparation comprising recombinant hcg
Inventor: COTTINGHAM IAN
IPC: A61K38/24
Filed: 2010-10-04
Abstract: Disclosed is recombinant human chorionic gonadotrophin (rhCG) including alpha2,3- and alpha2,6-sialylation and alpha2,8-sialylation.
Patent NZ-614351-A (NZ)
Title: Methods and compositions for treating complement-associated disorders
Inventor: BEDROSIAN CAMILLE
IPC: C07K16/24
Filed: 2009-11-10
Abstract: Discloses the use of an anti-C5 antibody in the manufacture of a medicament for reducing the occurrence or severity of thrombotic microangiopahty (TMA) in a patient who has, is suspected of having, or is at risk of developing TMA, wherein the patient does not have atypical haemolytic uremic syndrome (aHUS).
Patent NZ-617066-A (NZ)
Title: Nucleoside analogs
Inventor: NAGARATHNAM DHANAPALAN
IPC: C07H21/00
Filed: 2009-12-23
Abstract: The disclosure relates to a purified phosphoramidate nucleoside compound represented by formula (I) wherein R is OMe, OEt, -N(-CH2CH2CH2-) (azetidin-1-yl), or OH; or a salt, a pharmaceutically acceptable salt, a hydrate, a solvate, or a crystalline form thereof, which are suitable for the treatment of any condition the result of an infection by hepatitis C virus, West Nile virus, yellow fever virus, dengue virus, rhinovirus, polio virus, hepatitis A virus, bovine viral diarrhea virus or Japanese encephalitis virus.
Patent NZ-617989-A (NZ)
Title: Use of pnp inhibitors such as forodesine in combination with alkylating agents for treating hematologic cancers
Inventor: BREITFELD PHILIP
IPC: A61P35/02
Filed: 2008-12-10
Abstract: Disclosed are pharmaceutical composition comprising a (a) PNP inhibitor and (b) an alkylating agent. Also disclosed is the use of the composition in the treatment of hematologic cancer and a kit comprising (a) PNP inhibitor and (b) an alkylating agent and/or an anti-CD20 agent. An example of an PNP inhibitor is forodesine.
Patent NZ-618067-A (NZ)
Title: Anti-cd100 antibodies and methods for using the same
Inventor: FISHER TERRENCE LEE
IPC: C12P21/08
Filed: 2010-05-07
Abstract: Discloses an antibody which binds to CD100 consisting of at least CDR-H3: YYYGRHFDV and can further comprise CDR-H1: GYSFSDYYMH and CDR-H2: QINPTTGGASYNQKFKG.
Patent NZ-623857-A (NZ)
Title: 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same
Inventor: QUART BARRY D
IPC: C07D213/70
Filed: 2012-11-02
Abstract: Provided are pharmaceutical compositions comprising 2-((3-(4-cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid which are useful for reducing serum uric acid levels and treating gout, a recurrent gout attack, gouty arthritis, hyperuricaemia, hypertension, a cardiovascular disease, coronary heart disease, Lesch-Nyhan syndrome, Kelley-Seegmiller syndrome, kidney disease, kidney stones, kidney failure, joint inflammation, arthritis, urolithiasis, plumbism, hyperparathyroidism, psoriasis, sarcoidosis, and hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency.
Patent NZ-628160-A (NZ)
Title: Endophytes and related methods (2)
Inventor: RABINOVICH MAIA ANDREA
IPC: A01H17/00
Filed: 2011-01-07
Abstract: Disclosed is a method of analysing metabolites in a plurality of endophytes, said method including: providing: - a plurality of endophytes; and - a plurality of isogenic plants; - inoculating each isogenic plant with an endophyte; - culturing the endophyte-infected plants; and - analysing the metabolites produced by the endophyte-infected plants.
Patent NZ-720589-A (NZ)
Title: Welding process and product for inflatable product
Inventor: LIN HUA
IPC: B29C65/04
Filed: 2014-11-25
Abstract: A welding process of an inflatable product is provided that includes using isolating members between first and second portions of weldable tensioning members to resist the first and second portions of the weldable tensioning structures being welded together during welding of the first portions to a first sheet of weldable material and welding of the second portions to a second sheet of weldable material. The sheets cooperate to form an inflatable chamber and the isolating members and tensioning members remain inside the chamber.
Patent NZ-725625-A (NZ)
Title: Rocuronium preparation with improved stability
Inventor: JINBO KEISUKE
IPC: A61K31/5355
Filed: 2014-06-26
Abstract: The present invention provides a rocuronium formulation having excellent stability. This formulation includes rocuronium and a buffer solution, and has a pH adjusted to 3.5 or less (for example, 2.5-3.5). The buffer solution may be a citric acid/sodium hydroxide buffer solution, a tartaric acid/sodium hydroxide buffer solution, a potassium hydrogen phthalate/hydrochloric acid buffer solution, a glycine/hydrochloric acid buffer solution or the like. This type of rocuronium formulation has a rocuronium analog C generation rate of 5% or less after being stored for six months at 40 °C, for example.
Patent NZ-725880-A (NZ)
Title: Load suspension and weighing system for a dialysis machine reservoir
Inventor: FULKERSON BARRY NEIL
IPC: G01G9/00
Filed: 2013-11-05
Abstract: A load suspension system for a removable reservoir unit of a portable dialysis machine is described. The system includes a frame having a first plurality of members (110, 130, 115), said frame defining a structure around which a portion of said dialysis machine is formed; a top member (105) comprising a first connector for attaching said top member to at least one of said first plurality of members of the frame; a bottom member (135) comprising a second connector for attaching said bottom member to a second plurality of members configured to suspend a fluid container; and a circuit board (125) positioned between said top member and said bottom member;wherein said top member, bottom member, and circuit board are configured to be attached to said frame such that a load placed on the bottom member is translated through said bottom member and top member directly to said frame without placing said load on said circuit board.
Patent NZ-730945-A (NZ)
Title: Nerve cuff electrode for neuromodulation in large human nerve trunks
Inventor: FANG ZI-PING
IPC: A61N1/36
Filed: 2014-09-12
Abstract: A nerve cuff electrode is disclosed. The nerve cuff electrode comprises a self-curling nerve cuff with a plurality of conductive nerve contact segments. The segments have an inner surface configured to contact a nerve trunk and an outer surface configured not to contact the nerve trunk. The nerve cuff electrodes comprise at least one wire of a conductive biocompatible material operatively connecting the plurality of conductive nerve contact segments thus forming a segmented strip. The wire is configured as helical portions separated by non-helical portions where the non-helical portions are secured to the surface of the conductive nerve contact segments configured not to contact the nerve trunk. The nerve cuff electrode comprises a conductive lead capable of operatively connecting a waveform generator to at least one of the plurality of nerve contact segments. The helical structure of the wire improves durability and flexibility of the cuff electrode.